John Ostrominski, MD

John Ostrominski, MD, is a fellow in cardiovascular medicine and an obesity medicine specialist at Brigham and Women’s Hospital.

Articles by John Ostrominski, MD

Finerenone’s Efficacy in HF Unaffected by Concomitant CKM Components

ByJohn Ostrominski, MD

September 16th 2026

John Ostrominski, MD, discusses his analysis of the FINEARTS-HF trial, which showed finerenone’s improvements despite CKD, ASCVD, and/or metabolic disease.

John Ostrominski, MD

Articles by John Ostrominski, MD

Finerenone’s Efficacy in HF Unaffected by Concomitant CKM Components

Latest Updated Articles

Trending on HCPLive

Vicadrostat EASi-KIDNEY Trial Discontinued for Lack of Benefit in CKD

ASH Issues New Ferritin Thresholds for Iron Deficiency Diagnosis

Atacicept Cuts IgAN Progression Risk 76% in ORIGIN 3 Final Data

ARO-DIMER-PA Silences PCSK9, APOC3 in Mixed Hyperlipidemia

Dupilumab Cuts COPD Exacerbations Across Seasons, Smoking Status: Surya Bhatt, MD